CN1179735C - 一种治疗肝胆结石的溶石性药物及制备方法 - Google Patents

一种治疗肝胆结石的溶石性药物及制备方法 Download PDF

Info

Publication number
CN1179735C
CN1179735C CNB011340908A CN01134090A CN1179735C CN 1179735 C CN1179735 C CN 1179735C CN B011340908 A CNB011340908 A CN B011340908A CN 01134090 A CN01134090 A CN 01134090A CN 1179735 C CN1179735 C CN 1179735C
Authority
CN
China
Prior art keywords
ldrs
stone
medicine
oil
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CNB011340908A
Other languages
English (en)
Chinese (zh)
Other versions
CN1358530A (zh
Inventor
ΰ Ф
肖伟
戴翔翎
凌娅
李明慧
廖正根
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangsu Kanion Pharmaceutical Co Ltd
Original Assignee
Jiangsu Kanion Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Kanion Pharmaceutical Co Ltd filed Critical Jiangsu Kanion Pharmaceutical Co Ltd
Priority to CNB011340908A priority Critical patent/CN1179735C/zh
Publication of CN1358530A publication Critical patent/CN1358530A/zh
Priority to PCT/CN2002/000622 priority patent/WO2003037358A1/zh
Priority to US10/494,143 priority patent/US20050042308A1/en
Priority to JP2003539701A priority patent/JP4593918B2/ja
Application granted granted Critical
Publication of CN1179735C publication Critical patent/CN1179735C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534Mentha (mint)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/31Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A61K36/315Isatis, e.g. Dyer's woad
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/35Caprifoliaceae (Honeysuckle family)
    • A61K36/355Lonicera (honeysuckle)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539Scutellaria (skullcap)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
CNB011340908A 2001-10-29 2001-10-29 一种治疗肝胆结石的溶石性药物及制备方法 Expired - Lifetime CN1179735C (zh)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CNB011340908A CN1179735C (zh) 2001-10-29 2001-10-29 一种治疗肝胆结石的溶石性药物及制备方法
PCT/CN2002/000622 WO2003037358A1 (en) 2001-10-29 2002-09-05 A pharmaceutical composition having cholagogic and litholytic effect and its preparation method
US10/494,143 US20050042308A1 (en) 2001-10-29 2002-09-05 Pharmaceutical composition having cholagogic and litholytic effect and its preparation method
JP2003539701A JP4593918B2 (ja) 2001-10-29 2002-09-05 胆汁分泌促進、結石溶解作用を有する一種の薬物組成物、及びその製造方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB011340908A CN1179735C (zh) 2001-10-29 2001-10-29 一种治疗肝胆结石的溶石性药物及制备方法

Publications (2)

Publication Number Publication Date
CN1358530A CN1358530A (zh) 2002-07-17
CN1179735C true CN1179735C (zh) 2004-12-15

Family

ID=4672224

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB011340908A Expired - Lifetime CN1179735C (zh) 2001-10-29 2001-10-29 一种治疗肝胆结石的溶石性药物及制备方法

Country Status (4)

Country Link
US (1) US20050042308A1 (enExample)
JP (1) JP4593918B2 (enExample)
CN (1) CN1179735C (enExample)
WO (1) WO2003037358A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102210742B (zh) * 2010-04-09 2013-06-05 四川济生堂药业有限公司 薄荷素油在制备治疗胆汁淤积性肝病的药物中的应用
CN112516213B (zh) * 2020-12-30 2022-06-17 广西中医药大学 一种治疗胆结石的瑶药组合物、汤剂、胶囊剂及其应用
CN113421620B (zh) * 2021-05-17 2025-04-29 陕西中医药大学 基于uplc-q-tof/mse和整合效应的bp神经网络关联分析对中药不同功效的生物活性成分进行模糊识别的方法
CN113624707B (zh) * 2021-09-17 2024-06-18 云南博瑞生物科技有限公司 一种萝卜红气味定量检测方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60172925A (ja) * 1984-02-17 1985-09-06 Kao Corp 胆石溶解剤
JPH0757734B2 (ja) * 1990-10-09 1995-06-21 呉羽化学工業株式会社 鎮静用香料組成物および香粧品
CN1060964A (zh) * 1990-10-29 1992-05-13 洛洪程 一种热伤药物的制取方法
DE4330664A1 (de) * 1993-09-10 1995-03-16 Beiersdorf Ag Verwendungen von Pflanzenölen
JPH07242536A (ja) * 1994-03-01 1995-09-19 Toyo Capsule Kk 皮膜に精油成分が含有されたゼラチンカプセル剤
JP3828163B2 (ja) * 1994-06-10 2006-10-04 サンスター株式会社 抗炎症、抗かゆみ剤
EP0842604A1 (en) * 1996-11-13 1998-05-20 The Procter & Gamble Company Sprayable disinfecting compositions and processes for disinfecting surfaces therewith
IL129102A0 (en) * 1999-03-22 2000-02-17 J P M E D Ltd An emulsion
EP1146112A1 (en) * 2000-04-14 2001-10-17 The Procter & Gamble Company Process of cleaning and/or disinfecting a hard surface with a composition comprising a biguanide antimicrobial agent

Also Published As

Publication number Publication date
JP4593918B2 (ja) 2010-12-08
US20050042308A1 (en) 2005-02-24
CN1358530A (zh) 2002-07-17
WO2003037358A1 (en) 2003-05-08
JP2005514343A (ja) 2005-05-19

Similar Documents

Publication Publication Date Title
CN101039688A (zh) 用于预防或治疗尿失禁和膀胱过度活跃的草药组合物
CN1839815A (zh) 一种含有咖啡酰奎宁酸的药物组合物
CN1446577A (zh) 一种治疗小儿厌食症的药物组合物
CN1212134C (zh) 一种治疗泌尿系统感染和前列腺炎的中药复方制剂
CN100337662C (zh) 一种治疗高血脂症的药物组合物及其制备方法
WO2015190872A1 (ko) 스피루리나 추출물을 유효성분으로 함유하는 비만 예방 및 치료용 약학적 조성물
CN1245189C (zh) 一种扶正固本、健脾益肾,宁心安神,活血化淤的组合物
CN1323668C (zh) 一种药物组合物及其制药用途
CN1559495A (zh) 鹿胎颗粒中药制剂及生产工艺
CN1232267C (zh) 用于治疗脑血管疾病的组合物及其制备方法和应用
CN1056298C (zh) 一种治疗软组织损伤的外用药及其生产方法
CN1358530A (zh) 一种治疗肝胆结石的溶石性药物及制备方法
CN1709376A (zh) 治疗气滞型胃脘痛的中药复方制剂及其制备方法
CN1197612C (zh) 治疗泌尿系统结石和尿路感染疾病的中药制剂及其制备方法
CN1172711C (zh) 治疗慢性结膜炎的中药制剂
CN101062314A (zh) 一种治疗痛风的药物及其制备方法
CN1190228C (zh) 安宫止血药物
CN1159033C (zh) 一种妇科中药组合物
CN101703503A (zh) 有机二羧酸盐在防治白内障药物中的应用
KR102192586B1 (ko) 아위버섯의 추출물 또는 분말을 유효성분으로 함유하는 지방간 질환 치료용 약학적 조성물 및 간기능 개선용 건강기능식품
KR20000002474A (ko) 퇴행성 대뇌 신경계 질환의 예방 및 치료제
CN100335102C (zh) 治疗痛经的中药组合物及其制备方法
CN1660259A (zh) 一种治疗肠易激综合征的中药及其制备方法
RU2238755C1 (ru) Лечебно-профилактическое средство, обладающее гепатопротекторным, холестерино- и сахарорегулирующим действием (варианты)
CN100387252C (zh) 一种以薄荷素油为原料药制成用于治疗胆囊疾病的软胶囊

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
CX01 Expiry of patent term
CX01 Expiry of patent term

Granted publication date: 20041215